Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Showing 20 of 0 results

Not applicableStudy completedNCT05635539
What this trial is testing

Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial

Who this might be right for
Clinical Trial
University Medical Center, Kazakhstan 62
Early research (Phase 1)Study completedNCT01172054
What this trial is testing

Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
VaxInnate Corporation 292
Large-scale testing (Phase 3)Study completedNCT05479370
What this trial is testing

Immunogenicity Trial of 3 Influenza Vaccines

Who this might be right for
Influenza Vaccination
Tan Tock Seng Hospital 366
Large-scale testing (Phase 3)Study completedNCT03859141
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,340
Testing effectiveness (Phase 2)Study completedNCT05650554
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Not applicableStudy completedNCT05492786
What this trial is testing

High-risk Influenza Vaccine Alert

Who this might be right for
Influenza
Geisinger Clinic 80,452
Not applicableStudy completedNCT01098786
What this trial is testing

Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 556
Not applicableActive Not RecruitingNCT05019456
What this trial is testing

Exercise and COVID-19 Viral T-cell Immunity

Who this might be right for
COVID-19 Respiratory InfectionInfluenza
University of Arizona 26
Testing effectiveness (Phase 2)Study completedNCT01974895
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 316
Very early researchStudy completedNCT06831786
What this trial is testing

Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

Who this might be right for
COVID - 19
Prince of Songkla University 36
Not applicableStudy completedNCT00984451
What this trial is testing

A Pilot Study for Collection of Anti-Influenza A Immune Plasma

Who this might be right for
Influenza A Virus InfectionSwine Flu
National Institute of Allergy and Infectious Diseases (NIAID) 102
Not applicableEnded earlyNCT00359554
What this trial is testing

Influenza Vaccination of Nursing Home Workers.

Who this might be right for
Influenza Disease
Assistance Publique - Hôpitaux de Paris 4,000
Post-approval studies (Phase 4)Study completedNCT05512494
What this trial is testing

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 1,260
Not applicableEnrolling By InvitationNCT07164144
What this trial is testing

SAVE: School Ambassadors for Vaccine Education

Who this might be right for
Influenza Vaccination
University of Rochester 6,000
Testing effectiveness (Phase 2)Study completedNCT01258595
What this trial is testing

High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 300
Early research (Phase 1)Study completedNCT01250795
What this trial is testing

Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults

Who this might be right for
Healthy
Fraunhofer, Center for Molecular Biotechnology 100
Post-approval studies (Phase 4)Study completedNCT04997239
What this trial is testing

A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 600
Large-scale testing (Phase 3)Study completedNCT00996307
What this trial is testing

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

Who this might be right for
Influenza
Novartis Vaccines 654
Not applicableStudy completedNCT03637036
What this trial is testing

An Improvement Project Around Staffs' Influenza Vaccine Uptake

Who this might be right for
Influenza Vaccination
University of Warwick 8,438
Large-scale testing (Phase 3)Study completedNCT01884519
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation